2016
DOI: 10.14814/phy2.12671
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional profiling and muscle cross-section analysis reveal signs of ischemia reperfusion injury following total knee arthroplasty with tourniquet

Abstract: Total knee arthroplasty (TKA) is the most common and cost‐effective treatment for older adults with long‐standing osteoarthritis. Projections indicate that nearly 3.5 million older adults will undergo this procedure annually by the year 2030. Thus, understanding the factors that lead to optimal outcomes is of great clinical interest. In the majority of cases, tourniquet is applied during surgery to maintain a clear surgical field, however, there is debate as to whether this intervention is completely benign. I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
39
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 33 publications
(40 citation statements)
references
References 38 publications
(76 reference statements)
0
39
1
Order By: Relevance
“…Moreover, Akt and JNK interact with FOXO3a, and are regulated by inflammatory cytokines CXCL2, CXCL1, and CCL2, which we show in our transcriptional profiling, are upregulated. As well, MuRF1, a key regulator of the proteasomal pathway, is regulated by NFkB (and by FOXO3a), which is regulated by several molecules in our dataset including NFKBIZ, CYR61, KDM6B, MT1M, TNFRSF1A, HES1, and BCL3 (33). Therefore, our gene expression analysis shows that TKA with tourniquet induces expression of the molecular components of muscle atrophy.…”
Section: Introductionmentioning
confidence: 80%
See 4 more Smart Citations
“…Moreover, Akt and JNK interact with FOXO3a, and are regulated by inflammatory cytokines CXCL2, CXCL1, and CCL2, which we show in our transcriptional profiling, are upregulated. As well, MuRF1, a key regulator of the proteasomal pathway, is regulated by NFkB (and by FOXO3a), which is regulated by several molecules in our dataset including NFKBIZ, CYR61, KDM6B, MT1M, TNFRSF1A, HES1, and BCL3 (33). Therefore, our gene expression analysis shows that TKA with tourniquet induces expression of the molecular components of muscle atrophy.…”
Section: Introductionmentioning
confidence: 80%
“…The clinical view that tourniquet use is benign in older adults having TKA must be reevaluated in light of our recent data showing reductions in anabolic signaling (37) and up regulation of the catabolic FOXO (1) and UPR (14) pathways that precede, by a few hours, muscle cell swelling and gene clusters associated with cell stress (33). Muscle atrophy after TKA occurs at a rate of 1% per day (14% loss over 2 weeks), and slows significantly between 2 and 6 weeks post-TKA (i.e., −14% loss at 2 weeks vs. −18% at 6 weeks) (9).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations